a

3S Corporation is one of India’s leading stockist, exporter & wholesaler for Anti-cancer drug & Oncology medicines. We even supply & export Sex Enhancement Drugs, Cardiac & Anti Diabetic Medicines. We are a registered wholesaler & exporter for pharmaceutical products licensed by our FDA and Drug Controller in India. Our license number are 20-B/MZ6-23015 & 21-B/ MZ6-23016.

+(91)-(22)-42643060

3scorp.india@gmail.com
Andheri East, Mumbai - 400099, India.

DISCLAIMER

All the pharmaceutical products we offer are prescription drugs and should be used/taken under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug. We are not an online pharmacy . We do not recommend any drug or give medical advice. We only express opinions and provide information. Whether a medication is right for you is a decision between you and the prescribing doctor. Kindly seek medical advice from a registered doctor 0r hospital/Institution before taking any of these medicines.

Monday - Saturday

10.00 - 19.00

+(91)-(22)-42643060

3scorp.india@gmail.com

Andheri East

Mumbai – 400099, India.

Tocilizumab Injection 80,200 & 400 mg

  • recombinant humanized anti-human interleukin 6 (IL-6) receptor monoclonal antibody

Description

Tocilizumab is a recombinant humanized anti-human interleukin 6 (IL-6) receptor monoclonal antibody of the immunoglobulin IgG1κ (gamma 1, kappa) subclass with a typical H2L2 polypeptide structure.Tocilizumab Injection 80,200 & 400 mg is used in treatment of

Rheumatoid Arthritis (RA)

Tocilizumab is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more Disease-Modifying Anti-Rheumatic Drugs (DMARDs).

Polyarticular Juvenile Idiopathic Arthritis (PJIA)

Tocilizumab is indicated for the treatment of active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older.

Systemic Juvenile Idiopathic Arthritis (SJIA)

Tocilizumab is indicated for the treatment of active systemic juvenile idiopathic arthritis in patients 2 years of age and older.

India has many manufacturers who manufacture Tocilizumab Injection 80,200 & 400 mg .To know more contact us.

3s corporation is Supplier,Exporter ,Wholesaler  for Tocilizumab Injection 80,200 & 400 mg in India.

Additional Information

Tocilizumab Injection must be refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze.

Side Effects

Get emergency medical help if patient has any of these signs of an allergic reaction:

Hives;

Difficulty breathing;

Selling of your face, lips, tongue, or throat.

Serious and sometimes fatal infections may occur during treatment with tocilizumab. Call doctor right away if patient has signs of infection such as:

  • fever, flu symptoms, mouth and throat ulcers, weight loss, feeling very tired;
  • sores in your mouth and throat or on your skin;
  • easy bruising, unusual bleeding (nose, mouth, vagina, or rectum).

Pack Size